Quantcast
Last updated on April 19, 2014 at 17:21 EDT

Latest Healthcare in India Stories

2011-03-07 07:00:00

LOS ANGELES, March 7, 2011 /PRNewswire/ -- Genesis Biopharma, Inc. (OTC Bulletin Board: GNBP), a biotechnology company developing targeted cancer therapies, today announced it has named Marvin S. Hausman M.D. as Chief Science Officer. Dr. Hausman has 30 years of drug development and clinical care experience at various pharmaceutical companies. "We are very fortunate to have Marvin Hausman join the team at Genesis Biopharma," said Anthony J. Cataldo, President and Chief Executive Officer....

2011-03-03 06:30:00

CALGARY, March 3 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY), will present a corporate overview of the Company at the 31(st) Annual Cowen and Company Healthcare Conference on Tuesday, March 8(th), 2011 at 8:45 a.m. ET. The conference will take place from March 7(th) to 9(th) at the Marriott Copley Place in Boston, MA. A live audio link to the webcast presentation is available at:...

2011-03-02 15:00:00

SAN DIEGO, March 2, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President and CEO Ted Schroeder will present the company's corporate overview on Wednesday, March 9, 2011 at 8:00am Eastern Time (5:00am Pacific Time) during the Cowen and Company 31st Annual Health Care...

2011-03-01 08:00:00

HONG KONG, March 1 /PRNewswire/ - Today, www.WorldStreetFundamentals.com released its industry report highlighting Keryx Biopharmaceuticals (NASDAQ: KERX) and Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ). Investors from around the world are invited to view fundamental and technical analysis at www.WorldStreetFundamentals.com. Biotech is enabling creation of new drugs at a faster pace than previous traditional pharmaceutical models. After a decade of mediocre performance the sector...

2011-02-28 08:19:00

JERUSALEM, February 28, 2011 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals Inc. (OTCBB: ORMP), a developer of oral drug delivery systems, announced today that its subsidiary Oramed Ltd. entered into a Share Purchase Agreement with D.N.A Biomedical Solutions Ltd. (formerly Laser Detect Systems Ltd.), an Israeli company listed on the Tel Aviv Stock Exchange, for the sale of most of its holdings in Entera Bio Ltd., for $1.15 million, and a commitment by D.N.A to invest $250,000 in Oramed....

2011-02-25 15:00:00

SAN DIEGO, Feb. 25, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today announced that it will release its fourth quarter and full year ended December 31, 2010 financial results on Friday, March 4, 2011. Cadence management will host a conference call and live webcast to discuss the financial results on Friday,...

2011-02-24 06:30:00

CALGARY, Feb. 24 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY), will participate in a panel discussion at the RBC Capital Markets Healthcare Conference on Wednesday, March 2(nd), 2011 at 9:00 a.m. ET. The conference takes place at the New York Palace Hotel on March 2(nd) and 3(rd), 2011. A live audio link to the webcast presentation is available at:http://www.wsw.com/webcast/rbc129/rbc129.panel1, or on the company's website at...

2011-02-08 15:00:00

SAN DIEGO, Feb. 8, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences in February: -- BIO CEO & Investor Conference Date: Tuesday, February 15, 2011...

2011-01-12 07:45:21

(Ivanhoe Newswire) -- India is rapidly growing, with its economy progressing to make it one of the biggest players on the world stage. However, its health care and public health systems are not sufficient and fail to address the needs of its continually growing population, according to a series of seven papers published in The Lancet. Experts in the articles have pinpointed problems faced by India's health care system and call on the country to establish a truly universal health care system...

2011-01-04 16:13:00

MOUNTAIN VIEW, Calif., Jan. 4, 2011 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the company will present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011 at 8:00 a.m. PT in San Francisco. A live webcast of the presentation will be available on the Investor Relations section of MAP Pharmaceuticals' website at http://www.mappharma.com. A replay will also be available within 24 hours for seven days following the...